Form 483

Tarmac Products, Inc. Form 483, 2017-11-10

FDA issued a Form 483 to Tarmac Products, Inc. on 2017-11-10 with 9 public-safe observations.

483· Form 483 issuedHuman Drugs9 observations

Tarmac Products, Inc. · Miami Gardens, United States · Issued November 10, 2017

Overview

  • 9 public-safe observations are available for this inspection.
  • 9 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

10 Nov 2017
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Jose F Velez

10 Nov 2017
21 CFR 211.160(b)(4)

Establishment of calibration procedures

Cited by Jose F Velez

10 Nov 2017
21 CFR 211.165(d)

Acceptance criteria for sampling & testing

Cited by Jose F Velez

10 Nov 2017
21 CFR 211.194(a)

Complete test data included in records

Cited by Jose F Velez

10 Nov 2017
21 CFR 211.22(a)

Approve or reject components, products

Cited by Jose F Velez

Inspected site

TPTarmac Products, Inc.Miami Gardens, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)(4)Cited across public-safe Form 483 observations1x
21 CFR 211.165(d)Cited across public-safe Form 483 observations1x
21 CFR 211.194(a)Cited across public-safe Form 483 observations1x
21 CFR 211.22(a)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.56(a)Cited across public-safe Form 483 observations1x
21 CFR 211.67(a)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 9 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere